Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Arcutis Biotherapeutics, Inc. (ARQT) had Income from Continuous Operations of $-15.89M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$81.50M |
|
$-15.89M |
|
$7.49M |
|
$74.01M |
|
$96.11M |
|
$-14.61M |
|
$-0.93M |
|
$-15.54M |
|
$-15.54M |
|
$-15.89M |
|
|
Income from Continuous Operations |
$-15.89M |
$-15.89M |
|
$-15.89M |
|
$-14.61M |
|
$-14.90M |
|
127.00M |
|
127.00M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$332.78M |
|
$1.39M |
|
$19.66M |
|
$352.43M |
|
$103.94M |
|
$107.05M |
|
$109.52M |
|
$213.46M |
|
$138.97M |
|
$123.04M |
|
$138.97M |
|
119.80M |
|
| Cash Flow Statement Financials | |
$-30.06M |
|
$29.17M |
|
$1.77M |
|
$71.95M |
|
$73.05M |
|
$1.10M |
|
$20.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.20 |
|
-- |
|
-- |
|
0.44 |
|
0.78 |
|
90.81% |
|
-17.93% |
|
-17.93% |
|
-- |
|
-19.07% |
|
-19.49% |
|
$-30.74M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.46 |
|
0.76 |
|
117.81 |
|
-11.43% |
|
-12.91% |
|
-4.51% |
|
-6.46% |
|
$1.16 |
|
$-0.24 |
|
$-0.24 |
|